You have not yet registered? Get your account for free.
Forgot Password? We will send you a reset link
17 October 2019
Breath Therapeutics, a Zambon company, announces presentations at upcoming scientific conferences
26 March 2019
Breath Therapeutics Announces Initiation of Global Phase 3 Trials for the Treatment of Bronchiolitis Obliterans Syndrome
20 March 2019
Breath Therapeutics Announces Presentations at Upcoming Scientific Conferences
17 October 2018
Breath Therapeutics Appoints Peter Shadday as Chief Commercial Officer
11 July 2018
Breath Therapeutics Appoints Noreen Roth Henig, M.D. as Chief Medical Officer
28 November 2017
Breath Therapeutics appoints Renu Gupta as Executive Director
5 July 2017
Breath Therapeutics appoints Melissa Yeager as Chief Regulatory Officer
8 March 2017
Breath Therapeutics Raises EUR 43.5 Million in Series A Financing
